Cargando…
Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease
Several postmortem studies have shown iron accumulation in the substantia nigra of Parkinson’s disease patients. Iron concentration can be estimated via MRI- [Formula: see text] mapping. To assess the changes in [Formula: see text] occurring in Parkinson’s disease patients compared to controls, a mu...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668635/ https://www.ncbi.nlm.nih.gov/pubmed/36279753 http://dx.doi.org/10.1016/j.nicl.2022.103231 |
_version_ | 1784831957552594944 |
---|---|
author | Khedher, Laila Bonny, Jean-Marie Marques, Ana Durand, Elodie Pereira, Bruno Chupin, Marie Vidal, Tiphaine Chassain, Carine Defebvre, Luc Carriere, Nicolas Fraix, Valerie Moro, Elena Thobois, Stéphane Metereau, Elise Mangone, Graziella Vidailhet, Marie Corvol, Jean-Christophe Lehéricy, Stéphane Menjot de Champfleur, Nicolas Geny, Christian Spampinato, Umberto Meissner, Wassilios Frismand, Solène Schmitt, Emmanuelle Doé de Maindreville, Anne Portefaix, Christophe Remy, Philippe Fénelon, Gilles Luc Houeto, Jean Colin, Olivier Rascol, Olivier Peran, Patrice Durif, Franck |
author_facet | Khedher, Laila Bonny, Jean-Marie Marques, Ana Durand, Elodie Pereira, Bruno Chupin, Marie Vidal, Tiphaine Chassain, Carine Defebvre, Luc Carriere, Nicolas Fraix, Valerie Moro, Elena Thobois, Stéphane Metereau, Elise Mangone, Graziella Vidailhet, Marie Corvol, Jean-Christophe Lehéricy, Stéphane Menjot de Champfleur, Nicolas Geny, Christian Spampinato, Umberto Meissner, Wassilios Frismand, Solène Schmitt, Emmanuelle Doé de Maindreville, Anne Portefaix, Christophe Remy, Philippe Fénelon, Gilles Luc Houeto, Jean Colin, Olivier Rascol, Olivier Peran, Patrice Durif, Franck |
author_sort | Khedher, Laila |
collection | PubMed |
description | Several postmortem studies have shown iron accumulation in the substantia nigra of Parkinson’s disease patients. Iron concentration can be estimated via MRI- [Formula: see text] mapping. To assess the changes in [Formula: see text] occurring in Parkinson’s disease patients compared to controls, a multicentre transversal study was carried out on a large cohort of Parkinson’s disease patients (n = 163) with matched controls (n = 82). In this study, 44 patients and 11 controls were removed due to motion artefacts, 21 patient and 6 controls to preserve matching. Thus, 98 patients and 65 age and sex-matched healthy subjects were selected with enough image quality. The study was conducted on patients with early to late stage Parkinson's disease. The images were acquired at 3Tesla in 12 clinical centres. [Formula: see text] values were measured in subcortical regions of interest (substantia nigra, red nucleus, striatum, globus pallidus externus and globus pallidus internus) contralateral (dominant side) and ipsilateral (non dominant side) to the most clinically affected hemibody. As the observed inter-subject [Formula: see text] variability was significantly higher than the disease effect, an original strategy (intrasubject subcortical quantitative referencing, ISQR) was developed using the measurement of [Formula: see text] in the red nucleus as an intra-subject reference. [Formula: see text] values significantly increased in Parkinson’s disease patients when compared with controls; in the substantia nigra (SN) in the dominant side (D) and in the non dominant side (ND), respectively (P(SN_D) and P(SN_ND) < 0.0001). After stratification into four subgroups according to the disease duration, no significant [Formula: see text] difference was found in all regions of interest when comparing Parkinson’s disease subgroups. By applying our ISQR strategy, [Formula: see text] values significantly increased in the substantia nigra (P(SN_D) and P(SN_ND) < 0.0001) when comparing all Parkinson’s disease patients to controls. [Formula: see text] values in the substantia nigra significantly increased with the disease duration (P(SN_D) = 0.01; P(SN_ND) = 0.03) as well as the severity of the disease (Hoehn & Yahr scale <2 and ≥ 2, P(SN_D) = 0.02). Additionally, correlations between [Formula: see text] and clinical features, mainly related to the severity of the disease, were found. Our results support the use of ISQR to reduce variations not directly related to Parkinson’s disease, supporting the concept that ISQR strategy is useful for the evaluation of Parkinson’s disease. |
format | Online Article Text |
id | pubmed-9668635 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-96686352022-11-18 Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease Khedher, Laila Bonny, Jean-Marie Marques, Ana Durand, Elodie Pereira, Bruno Chupin, Marie Vidal, Tiphaine Chassain, Carine Defebvre, Luc Carriere, Nicolas Fraix, Valerie Moro, Elena Thobois, Stéphane Metereau, Elise Mangone, Graziella Vidailhet, Marie Corvol, Jean-Christophe Lehéricy, Stéphane Menjot de Champfleur, Nicolas Geny, Christian Spampinato, Umberto Meissner, Wassilios Frismand, Solène Schmitt, Emmanuelle Doé de Maindreville, Anne Portefaix, Christophe Remy, Philippe Fénelon, Gilles Luc Houeto, Jean Colin, Olivier Rascol, Olivier Peran, Patrice Durif, Franck Neuroimage Clin Regular Article Several postmortem studies have shown iron accumulation in the substantia nigra of Parkinson’s disease patients. Iron concentration can be estimated via MRI- [Formula: see text] mapping. To assess the changes in [Formula: see text] occurring in Parkinson’s disease patients compared to controls, a multicentre transversal study was carried out on a large cohort of Parkinson’s disease patients (n = 163) with matched controls (n = 82). In this study, 44 patients and 11 controls were removed due to motion artefacts, 21 patient and 6 controls to preserve matching. Thus, 98 patients and 65 age and sex-matched healthy subjects were selected with enough image quality. The study was conducted on patients with early to late stage Parkinson's disease. The images were acquired at 3Tesla in 12 clinical centres. [Formula: see text] values were measured in subcortical regions of interest (substantia nigra, red nucleus, striatum, globus pallidus externus and globus pallidus internus) contralateral (dominant side) and ipsilateral (non dominant side) to the most clinically affected hemibody. As the observed inter-subject [Formula: see text] variability was significantly higher than the disease effect, an original strategy (intrasubject subcortical quantitative referencing, ISQR) was developed using the measurement of [Formula: see text] in the red nucleus as an intra-subject reference. [Formula: see text] values significantly increased in Parkinson’s disease patients when compared with controls; in the substantia nigra (SN) in the dominant side (D) and in the non dominant side (ND), respectively (P(SN_D) and P(SN_ND) < 0.0001). After stratification into four subgroups according to the disease duration, no significant [Formula: see text] difference was found in all regions of interest when comparing Parkinson’s disease subgroups. By applying our ISQR strategy, [Formula: see text] values significantly increased in the substantia nigra (P(SN_D) and P(SN_ND) < 0.0001) when comparing all Parkinson’s disease patients to controls. [Formula: see text] values in the substantia nigra significantly increased with the disease duration (P(SN_D) = 0.01; P(SN_ND) = 0.03) as well as the severity of the disease (Hoehn & Yahr scale <2 and ≥ 2, P(SN_D) = 0.02). Additionally, correlations between [Formula: see text] and clinical features, mainly related to the severity of the disease, were found. Our results support the use of ISQR to reduce variations not directly related to Parkinson’s disease, supporting the concept that ISQR strategy is useful for the evaluation of Parkinson’s disease. Elsevier 2022-10-12 /pmc/articles/PMC9668635/ /pubmed/36279753 http://dx.doi.org/10.1016/j.nicl.2022.103231 Text en © 2022 Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Regular Article Khedher, Laila Bonny, Jean-Marie Marques, Ana Durand, Elodie Pereira, Bruno Chupin, Marie Vidal, Tiphaine Chassain, Carine Defebvre, Luc Carriere, Nicolas Fraix, Valerie Moro, Elena Thobois, Stéphane Metereau, Elise Mangone, Graziella Vidailhet, Marie Corvol, Jean-Christophe Lehéricy, Stéphane Menjot de Champfleur, Nicolas Geny, Christian Spampinato, Umberto Meissner, Wassilios Frismand, Solène Schmitt, Emmanuelle Doé de Maindreville, Anne Portefaix, Christophe Remy, Philippe Fénelon, Gilles Luc Houeto, Jean Colin, Olivier Rascol, Olivier Peran, Patrice Durif, Franck Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease |
title | Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease |
title_full | Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease |
title_fullStr | Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease |
title_full_unstemmed | Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease |
title_short | Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease |
title_sort | intrasubject subcortical quantitative referencing to boost mri sensitivity to parkinson's disease |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668635/ https://www.ncbi.nlm.nih.gov/pubmed/36279753 http://dx.doi.org/10.1016/j.nicl.2022.103231 |
work_keys_str_mv | AT khedherlaila intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT bonnyjeanmarie intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT marquesana intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT durandelodie intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT pereirabruno intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT chupinmarie intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT vidaltiphaine intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT chassaincarine intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT defebvreluc intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT carrierenicolas intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT fraixvalerie intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT moroelena intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT thoboisstephane intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT metereauelise intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT mangonegraziella intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT vidailhetmarie intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT corvoljeanchristophe intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT lehericystephane intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT menjotdechampfleurnicolas intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT genychristian intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT spampinatoumberto intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT meissnerwassilios intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT frismandsolene intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT schmittemmanuelle intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT doedemaindrevilleanne intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT portefaixchristophe intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT remyphilippe intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT fenelongilles intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT luchouetojean intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT colinolivier intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT rascololivier intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT peranpatrice intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT duriffranck intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease AT intrasubjectsubcorticalquantitativereferencingtoboostmrisensitivitytoparkinsonsdisease |